No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Specialties
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
www.clinicallaser.seNo one on the platform currently holds CLS-B.ST.
No tracked institution reports a position in CLS-B.ST as of their last filing.
No one on the platform has traded CLS-B.ST yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $28M | +2.2% | $0.00 | $0.00–$0.00 | — | 0 |
| 2027 | $67M | +136.6% | $0.00 | $0.00–$0.00 | — | 0 |
| 2028 | $130M | +92.9% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CLS-B.STClinical Laserthermia Systems AB (publ) | $1.89 | -0.42% | $60M | — |
| ANNX.STAnnexin Pharmaceuticals AB | $12.70 | -0.78% | $91M | — |
| BOUL.STBoule Diagnostics AB | $2.58 | -1.15% | $100M | — |
| BRAIN.STBrainCool AB (publ) | $0.92 | +3.38% | $362M | — |
| ERMA.STEnorama Pharma AB (publ) | $0.79 | +4.47% | $59M | — |
| INTEG-B.STIntegrum AB (publ) | $8.83 | -3.50% | $230M | — |
| ISOFOL.STIsofol Medical AB (publ) | $0.73 | -0.54% | $236M | — |
Source: Financial Modeling Prep · peers by sector/industry